166 related articles for article (PubMed ID: 37138198)
1. Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast Cancer Res Treat; 2023 Jul; 200(1):37-45. PubMed ID: 37138198
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
3. Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim YB; Chang JS; Choi DH; Kim H; Park YH; Kim DY; Kim TH; Kwon J; Kang KM; Chung WK; Kim KS; Kim IA
Breast; 2021 Dec; 60():272-278. PubMed ID: 34814043
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
[TBL] [Abstract][Full Text] [Related]
8. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
9. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.
Chao ST; Barnett GH; Vogelbaum MA; Angelov L; Weil RJ; Neyman G; Reuther AM; Suh JH
Cancer; 2008 Oct; 113(8):2198-204. PubMed ID: 18780319
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
11. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
Yomo S; Hayashi M
J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
[TBL] [Abstract][Full Text] [Related]
12. Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis.
Nicosia L; Figlia V; Mazzola R; Napoli G; Giaj-Levra N; Ricchetti F; Rigo M; Lunardi G; Tomasini D; Bonù ML; Corradini S; Ruggieri R; Alongi F
Clin Exp Metastasis; 2020 Feb; 37(1):77-83. PubMed ID: 31691873
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
14. Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases.
Gjyshi O; Lin SH; Pezzi TA; Ning MS; Ma J; Liu S; Rusthoven CG
Clin Lung Cancer; 2022 Mar; 23(2):185-190. PubMed ID: 34419375
[TBL] [Abstract][Full Text] [Related]
15. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
16. Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy.
Hsu F; Kouhestani P; Nguyen S; Cheung A; McKenzie M; Ma R; Toyota B; Nichol A
Radiother Oncol; 2013 Jul; 108(1):128-31. PubMed ID: 23742960
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.
Likhacheva A; Pinnix CC; Parikh NR; Allen PK; McAleer MF; Chiu MS; Sulman EP; Mahajan A; Guha-Thakurta N; Prabhu SS; Cahill DP; Luo D; Shiu AS; Brown PD; Chang EL
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):656-61. PubMed ID: 22898384
[TBL] [Abstract][Full Text] [Related]
18. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
[TBL] [Abstract][Full Text] [Related]
19. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.
Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
Strahlenther Onkol; 2010 Apr; 186(4):210-7. PubMed ID: 20165820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
